Amicus Therapeutics (FOLD) Accumulated Depreciation & Amortization (2016 - 2025)
Historic Accumulated Depreciation & Amortization for Amicus Therapeutics (FOLD) over the last 15 years, with Q3 2025 value amounting to $1.9 million.
- Amicus Therapeutics' Accumulated Depreciation & Amortization fell 1364.06% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year decrease of 1364.06%. This contributed to the annual value of $8.5 million for FY2024, which is 856.09% up from last year.
- Latest data reveals that Amicus Therapeutics reported Accumulated Depreciation & Amortization of $1.9 million as of Q3 2025, which was down 1364.06% from $1.9 million recorded in Q2 2025.
- Amicus Therapeutics' Accumulated Depreciation & Amortization's 5-year high stood at $8.5 million during Q4 2024, with a 5-year trough of $1.3 million in Q1 2023.
- For the 5-year period, Amicus Therapeutics' Accumulated Depreciation & Amortization averaged around $2.9 million, with its median value being $1.9 million (2025).
- In the last 5 years, Amicus Therapeutics' Accumulated Depreciation & Amortization plummeted by 3910.26% in 2021 and then soared by 7325.04% in 2023.
- Quarter analysis of 5 years shows Amicus Therapeutics' Accumulated Depreciation & Amortization stood at $6.2 million in 2021, then fell by 13.96% to $5.3 million in 2022, then skyrocketed by 47.38% to $7.9 million in 2023, then increased by 8.56% to $8.5 million in 2024, then tumbled by 78.07% to $1.9 million in 2025.
- Its Accumulated Depreciation & Amortization was $1.9 million in Q3 2025, compared to $1.9 million in Q2 2025 and $1.8 million in Q1 2025.